BEYFORTUS
Google image searchProduct monograph
Active ingredient
nirsevimab, 50 MG/0.5 ML
DIN: 02537206
Dosage form(s): SOLUTION
Route(s) of administration: INTRAMUSCULAR
Description: SINGLE-USE PRE-FILLED SYRINGE
Schedule: Schedule D
Company: SANOFI PASTEUR LIMITED
Date: 21-OCT-2024
ATC:
- J06 — IMMUNE SERA AND IMMUNOGLOBULINS (ATC, ATC/DDD, )
- J06B — IMMUNOGLOBULINS (ATC, ATC/DDD)
- J06BD — Antiviral monoclonal antibodies (ATC, ATC/DDD)
- J06BD08 — NIRSEVIMAB (ATC/DDD)
